This fifth briefing paper is provided through the RMOC system. It is the December edition of a series of briefings on best value biological medicines. The briefing summarises current aspects related to implementing best value biological medicines in the NHS. In particular, it provides an update on the procurement process.

 

The full briefing can be accessed here on the Specialist Pharmacy Service website.

 

All the adalimumab resources are available here.

 

More on